MENU
+Compare
REVS
ETF ticker: NYSE ARCA
AS OF
Jan 17 closing price
Price
$25.66
Change
+$0.18 (+0.71%)
Net Assets
64.07M

REVS stock forecast, quote, news & analysis

Category: @Large Value
REVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for REVS with price predictions
Jan 08, 2025

REVS's RSI Indicator ascends from oversold territory

The RSI Indicator for REVS moved out of oversold territory on December 23, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In of the 27 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where REVS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for REVS just turned positive on January 07, 2025. Looking at past instances where REVS's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where REVS advanced for three days, in of 351 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on REVS as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where REVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for REVS entered a downward trend on December 31, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are JPMorgan Chase & Co (NYSE:JPM), Exxon Mobil Corp (NYSE:XOM), Procter & Gamble Company (NYSE:PG), Johnson & Johnson (NYSE:JNJ), Oracle Corp (NYSE:ORCL), Bank of America Corp (NYSE:BAC), Salesforce (NYSE:CRM), Wells Fargo & Co (NYSE:WFC), Cisco Systems (NASDAQ:CSCO), QUALCOMM (NASDAQ:QCOM).

Industry description

The investment seeks investment results that, before fees and expenses, closely correspond to the performance of the Beta Advantage® Research Enhanced U.S. Value Index. The fund invests at least 80% of its assets in the securities of the index. The index reflects a rules-based strategic beta approach to investing in the companies that comprise the Russell 1000® Value Index, designed to achieve stronger total return when compared to the Russell 1000® Value Index, which is a broad measure of the performance of U.S. large- and mid-cap value companies.

Market Cap

The average market capitalization across the Columbia Research Enhanced Value ETF ETF is 36.55B. The market cap for tickers in the group ranges from 345.08M to 573.02B. JPM holds the highest valuation in this group at 573.02B. The lowest valued company is NLOP at 345.08M.

High and low price notable news

The average weekly price growth across all stocks in the Columbia Research Enhanced Value ETF ETF was 5%. For the same ETF, the average monthly price growth was 4%, and the average quarterly price growth was 9%. OZK experienced the highest price growth at 20%, while MRNA experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Columbia Research Enhanced Value ETF ETF was -19%. For the same stocks of the ETF, the average monthly volume growth was -10% and the average quarterly volume growth was 7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 48
Price Growth Rating: 45
SMR Rating: 55
Profit Risk Rating: 49
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
REVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category LargeValue

Profile
Fundamentals
Details
Category
Large Value
Address
Columbia ETF Trust I225 Franklin Street, Boston, MassachusettsBoston
Phone
617-426-3750
Web
N/A